Identification of Prognostic Gene Mutations in Biliary Tract Cancer Using Whole Genome Sequencing
NCT03718897 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2018-10-25
Summary
The purpose of this study is to investigate genetic mutations affecting prognosis using whole genome sequencing in patients with biliary tract cancer.
Conditions
- Biliary Tract Cancer
Interventions
- DIAGNOSTIC_TEST
-
Endoscopic retrograde cholangiopancreatogram
Biopsy specimens are attained via endoscopic retrograde cholangiopancreatogram in patients with suspicious biliary tract cancer.
Sponsors & Collaborators
-
Ji Kon Ryu
lead OTHER
Principal Investigators
-
Ji Kon Ryu, MD, phD · Seoul National University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-14
- Primary Completion
- 2020-09-02
- Completion
- 2022-09-02
Countries
- South Korea
Study Locations
More Related Trials
-
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Hepatobiliary Cancer Malignancies
NCT04835675 ·Status: COMPLETED
-
Artificial Intelligence-based Tumor Microenvironment Analysis for Prognosis Prediction in Gallbladder Cancer
NCT07092397 ·Status: COMPLETED
-
The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer
NCT05036486 ·Status: ACTIVE_NOT_RECRUITING
-
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer
NCT02790944 ·Status: COMPLETED
-
Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics
NCT05269056 ·Status: UNKNOWN
-
A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
NCT07176962 ·Status: RECRUITING
-
Clinical Application of Genetic Sequencing of Early Gastric Cancer and Gastric Adenoma Patients
NCT04665687 ·Status: RECRUITING
-
Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer
NCT02610218 ·Status: UNKNOWN
-
Microarray Analysis of Gene Expression in Liver Tumors
NCT00373737 ·Status: COMPLETED
-
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
NCT07035587 ·Status: RECRUITING
-
Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer
NCT02597179 ·Status: UNKNOWN
-
Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer
NCT03214991 ·Status: UNKNOWN
-
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)
NCT05693974 ·Status: UNKNOWN
-
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study)
NCT05693987 ·Status: UNKNOWN
-
Early Detection of Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics
NCT06083779 ·Status: UNKNOWN
-
Testing BRCA 1/2 Mutation Using Next Generation Sequencing
NCT02151747 ·Status: COMPLETED
-
Cancer Genome Analysis
NCT01458704 ·Status: UNKNOWN
-
Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer
NCT01831609 ·Status: UNKNOWN
-
Application of Chromosomal Instability in Early Diagnosis of Biliary Tract Carcinoma
NCT05845554 ·Status: RECRUITING
-
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC
NCT07076979 ·Status: RECRUITING
-
Genomic Profiling of Pancreatic Cystic Tumors
NCT06195904 ·Status: NOT_YET_RECRUITING
-
Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer
NCT02067754 ·Status: COMPLETED
-
Genomic Profiling in Cancer Patients
NCT01775072 ·Status: RECRUITING
-
Different Genetic Features Associated With Hepatic Carcinogenesis
NCT01247506 ·Status: UNKNOWN
-
Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection
NCT05585684 ·Status: RECRUITING